Compare Sana Biotechnology Inc (SANA) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Wells Fargo & Co — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Wells Fargo & Co trades at $87.8 (market cap $261.45B). The key difference: Wells Fargo & Co is far larger — about 299.2× Sana Biotechnology Inc's market cap, and Wells Fargo & Co pays a 2.09% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | WFC | |
|---|---|---|
Market Cap | $873.84M | $261.45B |
Sector | Health | Financials |
52-Week High | $5.92 | $96.40 |
52-Week Low | $2.68 | $73.42 |
Enterprise Value | $848.03M | — |
Dividend Yield | — | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
